Crossmark

A real-life study of elexacaftor-tezacaftor-ivacaftor therapy in people with cystic fibrosis in Brazil

Crossref DOI link: https://doi.org/10.1016/j.pulmoe.2023.03.008

Published Online: 2025-03-10

Published Print: 2023-11-30

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Salomão, L.Z.

Athanazio, R.A. https://orcid.org/0000-0002-9399-5275
Rached, S.Z.

Lopes-Pacheco, M. https://orcid.org/0000-0002-7444-9359
Camargo, M.
License Information

Version of Record valid from 2023-11-30
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=tpul20

Publication History

Received: 2023-02-15

Accepted: 2023-03-26

Published: 2025-03-10